Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when ENHA files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsCritical incident detected
Existential event
Time-sensitive event — see the red-flag panel below for the source-quoted detail.
Red Flags Detected
- Controlled Company (new) — Enhanced Group is a controlled company under NYSE rules due to its super-voting share structure, allowing it to forgo certain board independence requirements.
- Going Concern (new) — Management has concluded there is substantial doubt about the company's ability to continue as a going concern for one year after the financial statements were issued.
- Material Weakness (new) — The company has identified material weaknesses in its internal control over financial reporting relating to entity-level controls and financial close processes, third-party valuation reports, and user-access information-technology general controls.
Enhanced Group selling stockholders offer up to 12.9M shares; company receives no proceeds
Filed July 23, 2026 · ~2 min read
Key Changes
-
high
This is a resale registration for existing PIPE investors and insiders, not a primary offering. Enhanced Group receives zero proceeds from the shares being sold. The company may receive proceeds only if PIPE Warrant holders exercise for cash rather than cashless.
Use of Proceeds verify on EDGAR → -
high
Management has concluded there is substantial doubt about the company's ability to continue as a going concern for one year after the financial statements were issued. As of June 30, 2026, the company had $19.6 million in cash and cash equivalents.
-
high
The company has identified material weaknesses in its internal control over financial reporting relating to entity-level controls and financial close processes, third-party valuation reports, and user-access information-technology general controls.
Prospectus Summary verify on EDGAR → -
high
Enhanced Group is a controlled company under NYSE rules due to its super-voting share structure, allowing it to forgo certain board independence requirements.
-
high
The company's core business promotes sports events where athletes are permitted to use performance-enhancing substances under medical supervision, a model viewed as controversial and representing a departure from mainstream athletic competition. This may subject the company to reputational harm and difficulty securing venues, broadcasters, sponsors, and payment processors.
-
high
The inaugural 2026 Enhanced Games (held May 24, 2026 at Resorts World Las Vegas) generated over $32 million in contracted sponsorship value and reached over 1 billion people in a seven-day period, measured by social-media interactions. The event produced one world record and 21 personal bests.
Business view on EDGAR → -
high
The company has been unable to obtain third-party liability insurance for personal injury or death claims by athletes participating in the Enhanced Games. The company seeks to mitigate this exposure through medical and health assessments, but those measures may not prevent injuries or related claims.
-
medium
The company's ability to offer testosterone replacement therapy via telehealth depends on temporary COVID-19 flexibilities that expire December 31, 2026. If the temporary extension lapses or final DEA rules impose additional compliance burdens, the company's third-party telehealth providers may need to modify operations.
Business view on EDGAR →
Summary
Enhanced Group's selling stockholders are offering up to 12.9 million shares of Class A common stock (6.4 million Initial Shares and 6.4 million PIPE Warrant Shares) in a resale registration. The company receives no proceeds from this secondary offering; proceeds go entirely to the selling stockholders, who are institutional investors from a PIPE financing.
The company may receive proceeds only if PIPE Warrant holders exercise for cash rather than cashless exercise.
Enhanced Group became public through a SPAC-type business combination and operates two businesses: the Enhanced Games (a multi-sport competition platform where athletes are permitted to use performance-enhancing substances under medical supervision) and Live Enhanced (a subscription-based telehealth wellness platform launched in February 2026). The inaugural Enhanced Games held May 24, 2026 at Resorts World Las Vegas generated over $32 million in contracted sponsorship value and reached over 1 billion people in a seven-day period, producing one world record and 21 personal bests. The company's business model is controversial and unproven, with uncertain audience acceptance, sponsor interest, and regulatory treatment. The company faces significant financial and operational risks. Management has concluded there is substantial doubt about its ability to continue as a going concern for one year after the financial statements were issued; as of June 30, 2026, the company had $19.6 million in cash. The company has identified material weaknesses in its internal control over financial reporting. It has been unable to obtain third-party liability insurance for athlete injury or death claims. Enhanced Group is a controlled company under NYSE rules due to its super-voting share structure. The company's ability to offer testosterone replacement therapy via its Live Enhanced platform depends on temporary COVID-19 telehealth flexibilities that expire December 31, 2026, creating regulatory uncertainty.
Section-by-Section Diff
The Offering · The Offering
Selling securityholders offer up to 6,426,733 Initial Shares and up to 6,426,733 PIPE Warrant Shares; no proceeds to the company.
Added in current filing · verify on EDGAR →
Up to 6,426,733 Initial Shares and up to 6,426,733 PIPE Warrant Shares.
The selling securityholders are offering up to 6,426,733 Initial Shares and up to 6,426,733 PIPE Warrant Shares. This is a secondary offering; proceeds go to the selling securityholders, not to Enhanced Group Inc.
Added in current filing · verify on EDGAR →
if the last reported sale price of the Class A common stock equals or exceeds $20.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after May 24, 2026
The Sponsor's lock-up includes a price-based release: if Class A common stock trades at or above $20.00 per share for 20 out of any 30 trading days after May 24, 2026, the lock-up may be released early. This creates potential selling pressure if the stock reaches that threshold.
Prospectus Summary · Prospectus Summary
Enhanced Group operates the Enhanced Games multi-sport competition (inaugural event May 24, 2026 at Resorts World Las Vegas) and Live Enhanced subscription wellness offering (launched Feb 2026).
Added in current filing · verify on EDGAR →
Enhanced Group is a growth-stage sports entertainment, performance technology and lifestyle wellness company that is developing a portfolio of businesses centered around (i) the “Enhanced Games,” a multi-sport competition platform, the inaugural edition of which was held on May 24, 2026 at a purpose-built competition complex at Resorts World Las Vegas, and (ii) “Live Enhanced,” a subscription-based consumer performance and wellness offering that launched commercial operations in the United States in February 2026.
The company operates two main businesses: the Enhanced Games (a multi-sport competition platform with its first event held May 24, 2026 at Resorts World Las Vegas) and Live Enhanced (a subscription-based performance and wellness offering that launched commercially in the U.S. in February 2026). The company describes itself as growth-stage.
Added in current filing · verify on EDGAR →
Enhanced Group is the successor public company following the completion of the business combination between A Paradise, which was a BVI business company incorporated with limited liability, and Enhanced, which was a Cayman Islands exempted company (the “Business Combination”).
Enhanced Group became a public company through a business combination between A Paradise (a BVI company) and Enhanced (a Cayman Islands company). This indicates the company went public via a SPAC-type transaction rather than a traditional IPO.
Use of Proceeds · Use of Proceeds
Company receives no proceeds from selling securityholders' resale; may receive proceeds only from PIPE Warrant cash exercises.
Added in current filing · verify on EDGAR →
All of the shares of Class A common stock offered by the Selling Securityholders pursuant to this prospectus will be sold by the Selling Securityholders for their respective accounts. We will not receive any proceeds from the sale of our Class A common stock by the Selling Securityholders pursuant to this prospectus.
This is a resale registration for existing securityholders, not a primary offering. The company receives zero proceeds from the shares being sold. This is a post-Business Combination registration allowing insiders/PIPE investors to sell their shares to the public.
Added in current filing · verify on EDGAR →
However, we may receive proceeds from the exercise of the PIPE Warrants to the extent such warrants are exercised for cash, although we will not receive any proceeds from the resale of the PIPE Warrant Shares issued upon any such exercise.
The only potential proceeds to the company are from PIPE Warrant exercises if holders pay cash to exercise (rather than cashless exercise). The company receives nothing from the subsequent resale of those warrant shares.
Added in current filing · verify on EDGAR →
The Business Combination is accounted for as a reverse recapitalization in accordance with GAAP. Under this method of accounting, A Paradise, who was the legal acquirer, was treated as the “acquired” company for financial reporting purposes. Accordingly, for accounting purposes, Enhanced is treated as the accounting acquirer with the Business Combination treated as the equivalent of a capital transaction in which Enhanced is issuing shares for the net assets of A Paradise, accompanied by a recapitalization whereby no goodwill or other intangible assets are recorded.
Enhanced Group went public via SPAC merger with A Paradise. For accounting purposes, Enhanced is the acquirer (A Paradise was a shell company), so historical financials are Enhanced's, not A Paradise's. No goodwill is recorded in this reverse recapitalization structure.
Risk Factors · Risk Factors
Enhanced Group faces going-concern doubt with $19.6M cash, material weaknesses in controls, and an unproven business model around performance-enhanced sports.
Added in current filing · verify on EDGAR →
As of June 30, 2026, the Company had $19.6 million in cash and cash equivalents. Based on our current cash and cash equivalents and expected operating cash requirements, management has concluded that there is substantial doubt about our ability to continue as a going concern for one year after the date the condensed consolidated financial statements included in this prospectus were issued.
The company reports $19.6 million in cash and cash equivalents as of June 30, 2026, and management has concluded there is substantial doubt about its ability to continue as a going concern for one year after the financial statements were issued. The company states it has incurred substantial losses since inception and expects continued operating losses as it seeks to launch additional Enhanced Games events and develop the Live Enhanced platform.
Added in current filing · verify on EDGAR →
The material weaknesses identified for the Company were insufficient controls over (i) entity-level controls and financial close process affecting the control environment, control activities, information and communication and monitoring components (ii) third party valuation reports (iii) user-access information-technology general controls.
The company has identified material weaknesses in internal control over financial reporting relating to entity-level controls and financial close processes, third-party valuation reports, and user-access information-technology general controls. The company is working to remediate these weaknesses by hiring qualified staff and developing formal policies and procedures, but if unable to remediate successfully, it may not detect errors on a timely basis and financial statements may be materially misstated.
Added in current filing · verify on EDGAR →
The Company can provide no assurance that the Third Closing will occur in accordance with the terms of the Purchase Agreement or at all. If the Third Closing do not occur on the terms set forth in the Purchase Agreement or at all, the Company’s financial position may be materially and adversely affected.
The company expects the Third Closing under the Purchase Agreement to occur on or about August 6, 2026, following effectiveness of the Stockholder Consent, but provides no assurance it will occur as planned or at all. The Second Closing was completed on July 22, 2026, with Apeiron paying $11.75 million for 3,020,565 shares of Common Stock and accompanying warrants. If the Third Closing does not occur, the company's financial position may be materially and adversely affected.
Added in current filing · verify on EDGAR →
The Company is in the early stages of executing its business plan, has only conducted the inaugural 2026 Enhanced Games and first Enhanced Breakers event series and has a limited operating history as an organizer of sports events and coordinator of direct-to-consumer products. T ... he Company currently has limited revenues and does not expect to generate significant revenues unless and until it executes agreements relating to media rights, sponsorship and merchandising, and until its Live Enhanced services are operating more broadly.
The company has only conducted the inaugural 2026 Enhanced Games and first Enhanced Breakers event series, has limited operating history, and currently has limited revenues. It does not expect to generate significant revenues until it executes media rights, sponsorship, and merchandising agreements and expands its Live Enhanced services. The business model around performance-enhanced sports is novel and unproven, with uncertain audience acceptance, sponsor interest, and regulatory treatment.
Added in current filing · verify on EDGAR →
The creation and promotion of the Enhanced Games, and related events in which Enhanced Athletes are permitted to use Performance-Enhancing Substances and protocols under medical supervision represents a departure from mainstream athletic competition where athletes are prohibited from using such substances and protocols. ... These activities are viewed as controversial by some athletes, sport enthusiasts, the public and certain stakeholders because many traditional sports organizations and anti-doping bodies prohibit the use of performance-enhancing substances and protocols in sanctioned competition and have historically promoted policies discouraging their use.
The company's core business of promoting sports events where athletes are permitted to use performance-enhancing substances under medical supervision is viewed as controversial and represents a departure from mainstream athletic competition. This may subject the company to increased scrutiny, negative publicity, and reputational harm from regulators, traditional sports organizations, anti-doping agencies, and the public. Counterparties such as venues, broadcasters, sponsors, and payment processors may decline relationships due to reputational concerns, and the company may face limited analyst coverage and difficulties attracting institutional investors.
Added in current filing · verify on EDGAR →
The Company has identified material weaknesses in its internal control over financial reporting.
The company has identified material weaknesses in its internal control over financial reporting. This disclosure appears in block and indicates deficiencies in the company's financial reporting controls that could affect the reliability of its financial statements.
Added in current filing · verify on EDGAR →
if Enhanced Athletes do not outperform Non-Enhanced Athletes, or perform below the expected level, there is a risk that such events may not deliver the level of performance or entertainment value that audiences, sponsors, distribution partners and other stakeholders expect
The company's business model depends on Enhanced Athletes delivering superior performances. If athletes do not outperform or deliver expected results, demand for events could decline and the company may be unable to secure commercial arrangements. Although the inaugural 2026 Enhanced Games produced a world record and 21 personal bests, there is no assurance of comparable future performances.
Added in current filing · verify on EDGAR →
the Company does not have third-party liability insurance covering personal injury or death claims by athletes training for or participating in the Enhanced Games, and it has not been able to obtain such coverage due to the difficulty of underwriting that risk.
The company has been unable to obtain third-party liability insurance for personal injury or death claims by athletes participating in the Enhanced Games. The company seeks to mitigate this exposure through medical and health assessments, but those measures may not prevent injuries, adverse health outcomes, or related claims.
Business · Business
Enhanced Group monetizes its brand through Enhanced Games (live sports events with enhanced athletes) and Live Enhanced (a telehealth subscription platform).
Added in current filing · verify on EDGAR →
More than 1 billion people were reached and engaged over the May 24–30 period (as measured by the number of users who liked, shared, commented on, followed, or watched Enhanced content)
The company reports that its inaugural Enhanced Games in May 2026 reached and engaged over 1 billion people in a seven-day period, measured by social-media interactions. The event featured world records, streamed to 100 million North American homes via Roku, and generated over 4 million live views across multiple platforms. This is the company's first live event and the engagement metric is its primary evidence of market traction.
Added in current filing · verify on EDGAR →
As previously announced by the Company, the inaugural 2026 Enhanced Games generated over $32 million in contracted sponsorship value.
The company secured over $32 million in contracted sponsorship value for the inaugural 2026 Enhanced Games. This is the company's first disclosed revenue figure from its core business line (live events and sponsorship), though the filing does not state how much of this contracted value has been recognized as revenue or collected as cash.
Added in current filing · verify on EDGAR →
The Company does not directly employ physicians, nurse practitioners, or other licensed healthcare providers for the provision of clinical services. All clinical services available through the Live Enhanced platform are provided by third-party telehealth service providers pursuant to contractual arrangements with the Company.
The company operates a telehealth platform (Live Enhanced) but does not employ any physicians or clinical staff. All clinical services are provided by third-party telehealth vendors (OpenLoop and Beluga) under contract. The company operates the consumer-facing website, marketing, and non-clinical support, while the third parties handle clinical decision-making, prescriptions, pharmacy fulfillment, and medical records. This structure differs from other telehealth platforms that establish affiliated medical groups.
Added in current filing · verify on EDGAR →
The total expected cost of the Clinical Research Study is approximately $7 million over its full duration.
The company is conducting a clinical study in Abu Dhabi examining performance-enhancing substances in elite athletes, with 36 of 42 Enhanced Games athletes enrolled (34 in the interventional group receiving substances, 2 in observation-only). The study has IRB approval and a 5-year follow-up phase. Total cost is approximately $7 million.
Added in current filing · verify on EDGAR →
Aggregate all-inclusive costs for the 2026 Enhanced Games comprised approximately $6.5 million for the 50 meter pool, $2 million for the 150 meter track, and less than $100,000 for the weightlifting systems, in each case inclusive of design, materials, installation, and dismantling.
The company deployed temporary modular competition facilities at Resorts World Las Vegas for the May 24, 2026 Enhanced Games, with total infrastructure costs of approximately $8.6 million. The modular design is intended to reduce future capital requirements through reuse across future host sites.
Added in current filing · verify on EDGAR →
As a subscription-based direct-to-consumer lifestyle platform that delivers enhancements and OTC supplement blends through telehealth services, in addition to the typical legal and regulatory considerations faced by an early-stage company, we and our third-party telehealth service providers are required to comply with complex healthcare laws and regulations at both the state and federal level.
The Live Enhanced consumer platform operates through third-party telehealth service providers and is subject to extensive healthcare regulation including FDA product regulation, FTC advertising rules (including 2023 endorsement guidelines), state medical practice laws, and corporate practice of medicine restrictions. The company currently accepts only direct customer payments, not third-party payor reimbursement, which limits certain regulatory obligations but exposes it to evolving telehealth regulation.
Added in current filing · verify on EDGAR →
Performance-Enhancing Substances that may be administered as IMP under the IRB-approved protocol include: testosterone enanthate, testosterone cypionate, testosterone propionate and topical testosterone (including AndroGel); methenolone enanthate (Primobolan/Rimobolan); nandrolone decanoate (Deca-Durabolin); estradiol (patch or oral) and progesterone (topical or oral) as part of an HRT protocol; human growth hormone; erythropoietin/darbepoetin (including Aranesp); meldonium; modafinil; and mixed amphetamine salts (Adderall).
The clinical study administered market-authorized pharmaceutical products repurposed as investigational medicinal products, including anabolic steroids, peptide hormones, stimulants, and metabolic modulators. According to aggregate data released by the company, approximately 91% of enrolled athletes used testosterone esters. All substances are legal under FDA guidelines and no FDA Category 2 banned peptides were included.
Added in current filing · verify on EDGAR →
On December 30, 2025, the DEA and HHS jointly issued the Fourth Temporary Extension of COVID-19 telemedicine flexibilities (90 Fed. Reg. 61301), which became effective January 1, 2026 and runs through December 31, 2026. The Fourth Temporary Extension preserves the same substantive conditions that have applied since 2020, and does not impose new documentation, registration or technology requirements on practitioners. The agencies have stated that this extension is intended to avert a “telemedicine cliff” while they finalize permanent regulations. The DEA also published a proposed rule — the Special Registration for Telemedicine (90 Fed. Reg. 6541, January 17, 2025) — that would establish a permanent framework for telehealth prescribing of controlled substances without a prior in-person evaluation, including new registration, recordkeeping, reporting, and identity-verification requirements, and would regulate certain direct-to-consumer telehealth platforms as intermediaries. As of the date of this prospectus, that proposed rule has not been finalized. The DEA has indicated its intention to finalize permanent regulations before the current extension expires at the end of 2026. Whether the outcome is a permanent rule, a further extension, or a lapse in authority is uncertain.
The company's ability to offer TRT (testosterone replacement therapy, a Schedule III controlled substance) via telehealth depends on temporary COVID-19 flexibilities that expire December 31, 2026. The DEA has proposed permanent rules with new registration, recordkeeping, and identity-verification requirements, but has not finalized them. If the temporary extension lapses or final rules impose additional compliance burdens, the company's third-party telehealth providers may need to modify operations, increasing costs or reducing TRT availability.
Selling Stockholders · Selling Stockholders
Nine institutional investors may resell up to 13.1M shares of Class A common stock and warrants acquired in a PIPE financing.
Added in current filing · verify on EDGAR →
The percentages of shares owned before and after the offering are based on 128,657,186 shares of Class A common stock and 258,837,933 shares of Class B Common Stock, in each case, issued and outstanding as of June 17, 2026
The company has 128.7M Class A shares and 258.8M Class B shares outstanding as of June 17, 2026. The selling stockholders are nine institutional investors who acquired Class A shares and PIPE Warrants in a private placement (First Closing under a Purchase Agreement). The table shows these investors collectively hold approximately 13.6M Class A shares (including warrant shares exercisable within 60 days), which they may resell under this prospectus.
Show 2 minor / wording changes
Added in current filing · verify on EDGAR →
The exercise of the PIPE Warrants is subject to a 4.99% beneficial ownership blocker.
Multiple selling stockholders (Anson funds, Hudson Bay) have PIPE Warrants with a 4.99% beneficial ownership blocker, meaning they cannot exercise warrants if doing so would cause them to own more than 4.99% of the company's outstanding stock. Other investors have 9.99% blockers. These limitations prevent immediate dilution but do not prevent eventual full exercise and resale of all warrant shares.
Added in current filing · verify on EDGAR →
Shares owned prior to the offering consisted of (i) 499,999 shares of Class A common stock and (ii) 249,999 shares of Class A common stock issuable in respect of the exercise of the SAFE Warrants.
Castle Hook Master Fund held 500K Class A shares and 250K SAFE Warrant shares before the PIPE transaction, and acquired an additional 1.54M shares (771K shares plus 771K PIPE Warrant shares) in the PIPE financing. This indicates Castle Hook was an existing investor who participated in the new financing round.
Experts · Experts
WWC audited A Paradise (going concern doubt); BDO USA audited Enhanced Ltd (going concern doubt); Reed Smith opines on share validity.
Added in current filing · verify on EDGAR →
which contains an explanatory paragraph relating to the substantial doubt about the ability of A Paradise to continue as a going concern as described in Note 1 to the financial statements
The auditor WWC included an explanatory paragraph expressing substantial doubt about A Paradise's ability to continue as a going concern. This indicates the entity faces significant financial uncertainty that may affect its operations.
Added in current filing · verify on EDGAR →
The report on the financial statements contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
The auditor BDO USA included an explanatory paragraph regarding Enhanced Ltd's ability to continue as a going concern. This signals material uncertainty about the company's financial viability.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Reed Smith LLP has passed upon the validity of the shares of Class A common stock offered by this prospectus.
Reed Smith LLP provides the legal opinion on the validity of the Class A common stock being offered. This is standard disclosure confirming the shares are legally issued.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 17, 2026 · How we verify